GlassScriptPhysician profile
Diana Tabor
NPI 1659786150
$12,094.12
in general payments reported to CMS, 2019-2025
14 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,325 · 2020: $992 · 2021: $1,995 · 2022: $2,078 · 2023: $2,084 · 2024: $235 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,346 · Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,346.27 |
| Food and Beverage | $1,357.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,609.78 | 2019-2025 | Hoffmann, Salvation, Actishield Cf |
| Arthrex, INC. | $3,250.50 | 2019-2021 | |
| Medwest Associates | $1,974.86 | 2019-2022 | |
| International Life Sciences | $1,809.92 | 2023 | Flexband |
| Kerecis Limited | $601.75 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Wright Medical Technology, INC. | $240.99 | 2019-2020 | |
| Orthofix Medical, INC. | $196.33 | 2019-2024 | Physio-Stim, Spinal-Stim, Accelstim |
| Next Science LLC | $126.93 | 2022 | |
| Kci USA, INC. | $124.54 | 2019 | |
| Organogenesis INC. | $59.42 | 2019 | |
| Paragon 28, INC. | $53.17 | 2025 | Mtp |
| Fusion Orthopedics USA, LLC | $17.07 | 2024 | |
| Mimedx Group, INC. | $15.17 | 2025 | |
| Zyla Life Sciences, INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Tabor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.